Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Experimental study for a combination chemo-immunotherapy using dendritic cells].

Seigo Kashimura1, Masanori Terashima, Nobutoshi Soeta

  • 1First Dept. of Surgery, Fukushima Medical University.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 24, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of external radiation dose on pediatric peripheral blood components after the Great East Japan Earthquake: Fukushima Health Management Survey.

Scientific reports·2026
Same author

Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima health management survey.

Scientific reports·2026
Same author

Detection rate and maximum diameter of thyroid cysts among children and adolescents in thyroid ultrasound examination, The Fukushima Health Management Survey.

Endocrine journal·2026
Same author

Five Pathogenetic Classifications for Alloimmune Hemolytic Disease of the Fetus And Newborn.

Transfusion medicine reviews·2026
Same author

Association of severe stress with the onset of chronic kidney disease after the Great East Japan Earthquake: the Fukushima Health Management Survey.

Clinical and experimental nephrology·2025
Same author

T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia After CAR-T Therapy.

EJHaem·2025

Docetaxel (TXT) is identified as an optimal agent for combining chemotherapy and dendritic cell (DC) immunotherapy in gastric cancer. It effectively induces apoptosis in cancer cells and enhances Toll-like receptor-4 mRNA expression in DCs without suppressing immune cells.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Gastric cancer treatment often involves combination therapies.
  • Dendritic cell (DC) immunotherapy shows promise but requires optimal chemotherapeutic agents.
  • Identifying agents that support immunotherapy while targeting cancer is crucial.

Purpose of the Study:

  • To determine the optimal anticancer agent for combining chemotherapy with DC-based immunotherapy in gastric cancer.
  • To evaluate the immunomodulatory and cytotoxic effects of paclitaxel (TXL) and docetaxel (TXT).

Main Methods:

  • Assessed immunomodulatory effects on peripheral blood mononuclear cells (PBMC).
  • Measured apoptosis induction in gastric cancer cells.
  • Analyzed Toll-like receptor-4 (TLR-4) mRNA expression in immature dendritic cells (iDCs).

Related Experiment Videos

  • Compared cytotoxic T lymphocyte (CTL) activity induced by DCs pulsed with tumor lysate and apoptotic cells.

    • Main Results:

    • Docetaxel (TXT), doxifluridine, and irinotecan did not suppress PBMC proliferation.
    • Both TXL and TXT induced apoptosis in approximately 60% of gastric cancer cells.
    • TXT, but not TXL, upregulated TLR-4 mRNA expression in iDCs.
    • DCs pulsed with tumor lysate or apoptotic cells induced comparable CTL-mediated cytotoxicity.

    Conclusions:

    • Docetaxel (TXT) demonstrates favorable properties for combination therapy in gastric cancer.
    • TXT supports chemotherapy and DC immunotherapy by inducing apoptosis and enhancing DC maturation markers.
    • TXT is a potential optimal agent for integrating chemotherapy with DC immunotherapy for gastric cancer treatment.